Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations is a research paper published in The Oncologist (2025). On theSindex it has a DataRank of 0.307. It has been cited 6 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0156
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
NCI NIH HHS
Grant: P30 CA047904
NCI NIH HHS
Grant: R50 CA211241
NIH
Grant: S10OD028483
NIH
Grant: S10OD0234402
NIH
Grant: S10OD032141
The University of Pittsburgh Center for Research Computing and Data
HTC clusters
The University of Pittsburgh Center for Research Computing and Data (CRCD)
National Institutes of Health
National Institutes of Health (NIH)
MeSH Terms
Keywords